AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10997967
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no cytoreductive therapy)
Trial: 19994680
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (Flunarizine hydrochlorid capsules)
Trial: 11282668
Drug: Intranasal lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal lidocaine (1 mL of 4% lidocaine)
Trial: 8310996
Drug: 22-44 g
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 22-44 g pyruvate (n = 17)
Trial: 3335988
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg metoclopramide orally, 40‐45 min before procedure
Trial: 10671804
Drug: Reminiscence therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reminiscence therapy (n = 56)
Trial: 27499378
Drug: suPAR levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: suPAR levels (measured in log2 ng/mL)
Trial: 7536999
Drug: iloprost intravenously
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iloprost intravenously for 6 hours per day (mean dose: 1.7 ng/kg/min)
Trial: 7536999
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no trial therapy)
Trial: 7536999
Drug: iloprost treatment
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iloprost treatment
Trial: 31112954
Drug: Desidustat 100
RxNorm normalized name: Desidustat
DrugBank: Desidustat (DB16135)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desidustat 100 mg
Trial: 31112954
Drug: Desidustat 150
RxNorm normalized name: Desidustat
DrugBank: Desidustat (DB16135)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desidustat 150 mg
Trial: 31112954
Drug: Desidustat 200
RxNorm normalized name: Desidustat
DrugBank: Desidustat (DB16135)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desidustat 200 mg
Trial: 28851409
Drug: ECG device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECG device (Kardia Mobile) recording twice daily for 1 year
Trial: 10396713
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of 0.5% bupivacaine (group BIB)
Trial: 10396713
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of oxycodone in 10 ml of saline (group OIB)
Trial: 10396713
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of oxycodone intramuscularly (group OIM)
Trial: 7747715
Drug: Chemotherapy (Adriamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Adriamycin alone)
Trial: 26017589
Drug: Nitroglycerin ointment
RxNorm normalized name: Nitroglycerin Ointment
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin ointment
Trial: 29049211
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg 24 hours preoperative administration (EPEA)
Trial: 29049211
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg 1 hour preoperative administration (PEA)
Trial: 29049211
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg 4 hours postoperative administration (POA)
Trial: 27056950
Drug: Pritelivir treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pritelivir treatment (dosage not specified) for 28 days
Trial: 21961887
Drug: New Paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New Paracetamol pediatric suspension (PPS)
Trial: 16683415
Drug: Adjuvant platinum-based
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant platinum-based chemotherapy
Trial: 19258948
Drug: Observation after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation after surgical treatment
Trial: 12734607
Drug: Molsidomine 16
RxNorm normalized name: molsidomine
DrugBank: Molsidomine (DB09282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine 16 mg once-a-day
Trial: 15676171
Drug: Molsidomine 8
RxNorm normalized name: molsidomine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine 8 mg twice-a-day
Trial: 7655964
Drug: Pulse spray
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse spray thrombolysis with 0.33 mg/ml rt‐PA injected as a bolus of 0.2 ml
Trial: 7655964
Drug: Conventional thrombolysis
RxNorm normalized name: THROMBOLYTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional thrombolysis with 0.05 mg/ml rt‐PA infused at a rate of 10 ml/h
Trial: 19821962
Drug: Supplemental fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental fluid (prescribed plus 10 mL/kg) for 5 days
Trial: 14993586
Drug: Fiber (glucomannan)
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiber (glucomannan) 100 mg/kg body weight daily (max 5 g/day) for 4 weeks
Trial: 8260241
Drug: 3M chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3M chemotherapy alone
Trial: 3631731
Drug: Greater level
RxNorm normalized name: greater celandine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Greater level of effort while breathing room air (25.0 ± 0.4 degrees C, 15.7 ± 0.2 mg H2O/L)
Trial: 20080017
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg or 8 mg in adults; 0.15 mg/kg in children
Trial: 20080017
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg in adults
Trial: 12586255
Drug: ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe 10 mg plus lovastatin (10, 20, or 40 mg)
Trial: 1662877
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg or 750 mg b.i.d.
Trial: 6789358
Drug: Reserpine at
RxNorm normalized name: Reserpine
DrugBank: Reserpine (DB00206)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reserpine at doses of 0.75‐1.5 mg daily
Trial: 6789358
Drug: Alpha‐methyldopa at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha‐methyldopa at doses of 750‐1,500 mg daily
Trial: 22344322
Drug: Multivalent polyclonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivalent polyclonal antibody preparation (PAP) at 10 mL·d(‐1)
Trial: 22344322
Drug: Monensin (MON)
RxNorm normalized name: Monensin
DrugBank: Monensin (DB11430)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monensin (MON) at 300 mg·d(‐1)
Trial: 22344322
Drug: Crossbred yearling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crossbred yearling bulls (TC and CC)
Trial: 30474791
Drug: IV paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV paracetamol (1000 mg)
Trial: 22385032
Drug: Prescription aluminum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription aluminum chloride (6.5%) antiperspirant
Trial: 20491723
Drug: Motivation Enhancement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivation Enhancement Treatment (MET)
Trial: 7036282
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with levamisole
Trial: 21617197
Drug: Low-dose sirolimus
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sirolimus (Low-SRL)
Trial: 21617197
Drug: Low-dose tacrolimus
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose tacrolimus (Low-Tac)
Trial: 21617197
Drug: Standard-dose cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose cyclosporine (Stand-CsA) and Low-dose cyclosporine (Low-CsA)
Trial: 19020496
Drug: Erythromycin (as
RxNorm normalized name: erythromycin (as lactobionate)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (as a prototypical irreversible inhibitor of CYP3A)
Trial: 17870625
Drug: Thoracic epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic epidural bupivacaine and morphine
Trial: 15356075
Drug: Intranasal atrial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal atrial natriuretic peptide (ANP) 1 mg
Trial: 9069306
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (CT) plus radiation therapy (RT)
Trial: 8450399
Drug: Pharmacological dose
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological dose of recombinant human growth hormone (5.0 mg, every other day)
Trial: 8450399
Drug: Physiological dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological dose of recombinant human growth hormone (2.5 mg, every other day)
Trial: 3528672
Drug: G 115
RxNorm normalized name: penicillin G benzathine 115 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G 115 (100 mg twice a day for 12 weeks)
Trial: 25708488
Drug: Fluconazole (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (6 mg/kg)
Trial: 27129005
Drug: Omeprazole (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (60 mg)
Trial: 27129005
Drug: Ritonavir (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir (30 mg)
Trial: 21901480
Drug: 300 mg/day
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/day isoflavones (aglycone equivalents)
Trial: 17497593
Drug: BCAA drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA drink containing 2 g of BCAA and 0.5 g of Arg
Trial: 11684077
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of atorvastatin
Trial: 16253583
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of pravastatin
Trial: 15023882
Drug: Clopidogrel (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (375 mg loading dose, followed by 75 mg/d for at least 3 months)
Trial: 7771954
Drug: Lovastatin (L)
RxNorm normalized name: Lovastatin
DrugBank: Lovastatin (DB00227)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lovastatin (L) 20 mg/day
Trial: 29258695
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT)
Trial: 27846913
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy (CCRT) alone
Trial: 27630213
Drug: Understanding that
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Understanding that psychological treatment was not offered
Trial: 27630213
Drug: Incorrect indication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incorrect indication of participation replacing current psychological treatment
Trial: 26351776
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3 supplementation that raised 25(OH)D levels to ≥32 ng/mL
Trial: 23512062
Drug: Eritoran (105
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eritoran (105 mg total over 6 days)
Trial: 20483152
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose chemotherapy
Trial: 8749780
Drug: Low or
RxNorm normalized name: Milkflow oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low or standard dose chemotherapy
Trial: 8749780
Drug: Different treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different treatment regimens
Trial: 2293142
Drug: Codeine 60
RxNorm normalized name: codeine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine 60 mg plus paracetamol 1 g 3 times daily
Trial: 30630183
Drug: Topical Lactococcus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Lactococcus lactis emulsion applied once daily for 4 days on reconstructed human epidermis
Trial: 26358536
Drug: Parent and
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent and child family-based treatment (FBT)
Trial: 15210457
Drug: Narrowband UV-B
RxNorm normalized name: Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrowband UV-B (NB-UV-B) phototherapy, 3 times a week for either 60 treatments or 6 months
Trial: 19774117
Drug: MA‐ES 625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MA‐ES 625 mg/5 mL with a high-calorie, high-fat meal
Trial: 19774117
Drug: MAOS 800
RxNorm normalized name: Mao cang zhu rhizome
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAOS 800 mg/20 mL
Trial: 15570274
Drug: Ligation and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ligation and vein stripping (S and L)
Trial: 10683000
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg) plus vitamin B6 (250 mg) daily for 2 years
Trial: 15681958
Drug: Placebo Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo Patch
Trial: 25976467
Drug: Hydroxyurea (HU)
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea (HU) treatment (dosage > 20 mg/kg/day)
Trial: 18979086
Drug: 25-g glucose
RxNorm normalized name: glucose 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25-g glucose drink
Trial: 31852268
Drug: bDMARDs (biologic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bDMARDs (biologic disease-modifying anti-rheumatic drugs)
Trial: 31852268
Drug: csDMARDs (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: csDMARDs (conventional synthetic disease-modifying anti-rheumatic drugs)
Trial: 31852268
Drug: cyclosporine and
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cyclosporine and TNF inhibitors
Trial: 27856142
Drug: Onartuzumab (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onartuzumab (15 mg/kg intravenously every 3 weeks) in combination with bevacizumab-based chemotherapy
Trial: 27856142
Drug: Onartuzumab (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onartuzumab (15 mg/kg intravenously every 3 weeks) in combination with pemetrexed-based chemotherapy
Trial: 27856142
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in combination with bevacizumab-based chemotherapy
Trial: 27856142
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in combination with pemetrexed-based chemotherapy
Trial: 22366196
Drug: Aclidinium 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aclidinium 200 μg, 400 μg, 800 μg, twice daily for 7 days
Trial: 22366196
Drug: Aclidinium (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aclidinium (all doses), twice daily for 7 days
Trial: 18979100
Drug: Combined intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined intra-arterial chemotherapy
Trial: 2339013
Drug: Amitriptyline +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline + psychotherapy (N = 26), twelve 45 min weekly sessions
Trial: 31358922
Drug: Intravitreal Conbercept
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal Conbercept injections (three loading doses and thereafter pro re nata [PRN])
Trial: 31358922
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (3 months' sham injection, then one Conbercept injection at month 4 and thereafter PRN)
Trial: 11719888
Drug: Placebo (maltodextrine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (maltodextrine, 4 times daily for 5 days)
Trial: 2465530
Drug: Carbamazepine (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (800 mg/day)
Trial: 29102818
Drug: Paroxetine, 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine, 12 weeks of open treatment
Trial: 21985070
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg day(-1)
Trial: 15515816
Drug: ccHRT (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ccHRT (50 mg of 17beta‐estradiol and 5 mg of oral progesterone)
Trial: 11273923
Drug: Rectal acetaminophen
RxNorm normalized name: acetaminophen Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal acetaminophen 10 mg/kg
Trial: 29633166
Drug: Vilazodone 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilazodone 15 mg/day
Trial: 29633166
Drug: Vilazodone 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilazodone 30 mg/day
Trial: 30658660
Drug: BMF (Chinese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMF (Chinese herbal medicine bi min fang)
Trial: 27618925
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of penicillin V four times daily for 5 days
Trial: 19835718
Drug: Drospirenone 3
RxNorm normalized name: drospirenone 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drospirenone 3 mg/ethinyl estradiol 20 mcg (drsp 3 mg/EE 20 mcg)
Trial: 14998051
Drug: Experimental power
RxNorm normalized name: guaifenesin
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Experimental power toothbrush (twice a day brushing with Crest Cavity Protection dentifrice for 2 minutes each time)
Trial: 14998051
Drug: Peroxide paint-on
RxNorm normalized name: Castellani Paint
DrugBank: Phenol (DB03255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peroxide paint-on gel control (Colgate Simply White Night applied once a day for the first 14 days, plus brushing twice a day with Crest Cavity Protection dentifrice for 2 minutes using ADA manual reference toothbrush)
Trial: 2515593
Drug: Sucralfate 2
RxNorm normalized name: sucralfate 200 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate 2 g b.i.d.
Trial: 1882907
Drug: Sucralfate 1
RxNorm normalized name: sucralfate 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate 1 g q.i.d.
Trial: 6882613
Drug: alcuronium 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alcuronium 0.03 mg kg‐1
Trial: 6882613
Drug: tubocurarine 0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tubocurarine 0.06 mg kg‐1
Trial: 6882613
Drug: pancuronium 0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pancuronium 0.01 mg kg‐1
Trial: 28617764
Drug: Oropharyngeal administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oropharyngeal administration of 0.2 mL of mother's colostrum every 4 hours for 7 days
Trial: 24422892
Drug: Secondary cytoreductive
RxNorm normalized name: Secondary potassium phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secondary cytoreductive surgery followed by at least six cycles of intravenous platinum-based chemotherapy
Trial: 24422892
Drug: At least
RxNorm normalized name: Lovaza 1000 MG (at least 900 MG) Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: At least six cycles of intravenous platinum-based chemotherapy
Trial: 17898947
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine group (WM group) treated with prednisone for 6 months.
Trial: 12195686
Drug: Ramipril 2.5
RxNorm normalized name: ramipril 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 2.5 mg orally prior to thrombolysis and 12 hours later
Trial: 24892114
Drug: 1-stage lateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-stage lateral window sinus lift with simultaneous implant placement
Trial: 11218582
Drug: Ureaplasma urealyticum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ureaplasma urealyticum colonization in infants with birth weight of 1,000 g or less
Trial: 9396895
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of pharmacy-prepared intravaginal prostaglandin E2 gel
Trial: 31603201
Drug: EBOV GP
RxNorm normalized name: carbetapentane citrate / guaifenesin Oral Solution [Pulmari-GP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EBOV GP vaccine with Matrix‐M adjuvant (2 doses)
Trial: 29924240
Drug: U-MDT regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U-MDT regimen (six doses of MB-MDT: rifampicin, dapsone, and clofazimine)
Trial: 21541732
Drug: 2.4 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.4 g/day CLA mixture (36.9% cis-9, trans-11 and 37.9% trans-10, cis-12)
Trial: 21541732
Drug: Placebo (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2.4 g olive oil/day)
Trial: 21991730
Drug: Rocuronium 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.3 mg kg(‐1)